{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%3B+placebo+comparator+condition&page=56", "query": { "intervention": "Placebo; placebo comparator condition", "page": 56 }, "page_size": 10 }, "pagination": { "page": 56, "page_size": 10, "total_count": 7773, "total_pages": 778, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%3B+placebo+comparator+condition&page=57&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%3B+placebo+comparator+condition&page=55&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T00:17:59.835Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03625401", "title": "Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer Disease, Early Onset" ], "interventions": [ { "name": "AD-35 60mg group", "type": "DRUG" }, { "name": "Placebo group", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zhejiang Hisun Pharmaceutical Co. Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 55, "start_date": "2018-10-04", "completion_date": "2020-12-31", "has_results": false, "last_update_posted_date": "2020-03-25", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 10, "location_summary": "Sacramento, California • San Diego, California • Delray Beach, Florida + 7 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Delray Beach", "state": "Florida" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Maitland", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03625401" }, { "nct_id": "NCT04865536", "title": "Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Tuberculosis", "Tuberculosis, Pulmonary" ], "interventions": [ { "name": "TBI-223 1800 mg", "type": "DRUG" }, { "name": "TBI-223 2400mg", "type": "DRUG" }, { "name": "TBI-223 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Global Alliance for TB Drug Development", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "19 Years to 50 Years" }, "enrollment_count": 28, "start_date": "2021-02-03", "completion_date": "2022-05-17", "has_results": false, "last_update_posted_date": "2025-06-05", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 1, "location_summary": "Fair Lawn, New Jersey", "locations": [ { "city": "Fair Lawn", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04865536" }, { "nct_id": "NCT03279731", "title": "Binge Eating Liraglutide Intervention", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Binge-Eating Disorder" ], "interventions": [ { "name": "Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kelly Allison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 36, "start_date": "2017-09-29", "completion_date": "2019-10-01", "has_results": true, "last_update_posted_date": "2020-11-24", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03279731" }, { "nct_id": "NCT02968212", "title": "Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mycobacterium Avium Complex" ], "interventions": [ { "name": "Clofazimine", "type": "DRUG" }, { "name": "sugar pill", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 102, "start_date": "2017-04-11", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 6, "location_summary": "Denver, Colorado • Tampa, Florida • Chicago, Illinois + 3 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT02968212" }, { "nct_id": "NCT05620407", "title": "A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Deucravacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 513, "start_date": "2023-01-12", "completion_date": "2028-11-13", "has_results": false, "last_update_posted_date": "2025-12-02", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 39, "location_summary": "La Jolla, California • La Mesa, California • San Diego, California + 34 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Leandro", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05620407" }, { "nct_id": "NCT02437383", "title": "Study of Orofacial Pain and PropRANOlol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Temporomandibular Disorders" ], "interventions": [ { "name": "Propranolol ER", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 200, "start_date": "2015-08-20", "completion_date": "2018-04-25", "has_results": true, "last_update_posted_date": "2019-05-21", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 3, "location_summary": "Gainesville, Florida • Buffalo, New York • Chapel Hill, North Carolina", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Buffalo", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02437383" }, { "nct_id": "NCT00534001", "title": "Bupropion in Helping Adults Stop Smoking", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bladder Cancer", "Cervical Cancer", "Esophageal Cancer", "Gastric Cancer", "Head and Neck Cancer", "Kidney Cancer", "Leukemia", "Liver Cancer", "Lung Cancer", "Pancreatic Cancer", "Tobacco Use Disorder" ], "interventions": [ { "name": "bupropion hydrochloride", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 95, "start_date": "2006-01", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00534001" }, { "nct_id": "NCT04476030", "title": "A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "SAGE-217", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" }, { "name": "Escitalopram", "type": "DRUG" }, { "name": "Citalopram", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" }, { "name": "Desvenlafaxine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 440, "start_date": "2020-11-09", "completion_date": "2021-12-22", "has_results": true, "last_update_posted_date": "2023-12-22", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 51, "location_summary": "Dothan, Alabama • Phoenix, Arizona • Anaheim, California + 42 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04476030" }, { "nct_id": "NCT02617667", "title": "CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Eye Syndromes" ], "interventions": [ { "name": "Cyclosporine A", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novaliq GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 207, "start_date": "2016-01", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2019-11-06", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 4, "location_summary": "Newport Beach, California • Lewiston, Maine • Andover, Massachusetts + 1 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Lewiston", "state": "Maine" }, { "city": "Andover", "state": "Massachusetts" }, { "city": "Quincy", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02617667" }, { "nct_id": "NCT01931202", "title": "Mechanisms of Antidepressant Non-Response in Late-Life Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Escitalopram", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "60 Years to 90 Years" }, "enrollment_count": 138, "start_date": "2014-02-19", "completion_date": "2020-01-17", "has_results": true, "last_update_posted_date": "2020-07-02", "last_synced_at": "2026-10-18T00:17:59.835Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01931202" } ] }